These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


678 related items for PubMed ID: 15068837

  • 21. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
    Harris RE, Alshafie GA, Abou-Issa H, Seibert K.
    Cancer Res; 2000 Apr 15; 60(8):2101-3. PubMed ID: 10786667
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia.
    Linder JD, Mönkemüller KE, Davis JV, Wilcox CM.
    South Med J; 2000 Sep 15; 93(9):930-2. PubMed ID: 11005360
    [Abstract] [Full Text] [Related]

  • 27. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.
    Khan AA, Brahim JS, Rowan JS, Dionne RA.
    Clin Pharmacol Ther; 2002 Jul 15; 72(1):44-9. PubMed ID: 12152003
    [Abstract] [Full Text] [Related]

  • 28. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN.
    Cancer Res; 2000 Nov 01; 60(21):6045-51. PubMed ID: 11085526
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C.
    Bull Cancer; 2004 May 01; 91 Spec No():S125-31. PubMed ID: 15239341
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May 01; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 36. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H.
    Cancer; 2003 Aug 15; 98(4):661-7. PubMed ID: 12910508
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G, Cravero E.
    Clin Ter; 2003 Aug 15; 154(1):39-43. PubMed ID: 12854282
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.